-
Depomed Nearing Daily Breakout
Tuesday, August 16, 2011 - 1:09pm | 117Shares of Depomed (NASDAQ: DEPO) are on the rise today; currently, shares are higher by 0.93%, trading at $5.41. The stock has found daily resistance at the $5.45 level several times and is currently revisiting the level. A break above $5.45 would mean that shares of Depomed would test the daily...
-
Abbott Expanding Manufacturing Capacity in China
Tuesday, August 16, 2011 - 11:02am | 58Abbott (NYSE: ABT) announced today that it will invest $230 million (USD) to build a state-of-the-art nutrition manufacturing facility in Jiaxing, China. The facility represents Abbott's largest investment in China to date and will manufacture premium powdered milk products for Chinese infants and...
-
Marshall Edwards Screams Higher
Tuesday, August 16, 2011 - 9:32am | 115Shares of Marshall Edwards (NASDAQ: MSHL) are screaming higher this morning on word that its Investigational New Drug application for ME-143, the Company's lead NADH oxidase inhibitor, has been approved by the FDA. Currently, shares are higher by 52.90%, trading at $2.11. Shares of Novogen Limited...
-
Credit Suisse Upgrading Allergan
Tuesday, August 16, 2011 - 8:30am | 122Credit Suisse is upgrading shares of Allergan Inc (NYSE: AGN) to Outperform and it has a $91 price target on shares. In a note to clients, Credit Suisse writes, "The recent downturn in consumer sentiment and associated pullback in AGN provide an entry point, ironically the prominent growth drivers...
-
Icagen Reiterates Its Recommendation That Stockholders Accept Pfizer's Offer of $6 Per Share
Tuesday, August 16, 2011 - 7:32am | 343Icagen, Inc. (Nasdaq: ICGN) announced today that it has mailed the following letter to stockholders reiterating its recommendation that Icagen stockholders accept the $6 per share tender offer by Pfizer Inc. (NYSE: PFE): August 16, 2011 Dear Icagen Stockholder: You should have recently received...
-
Perrigo Announces Planned $350M Private Placement of Notes
Tuesday, August 16, 2011 - 7:11am | 207Perrigo Company (Nasdaq: PRGO) today announced it expects to issue $350 million of notes in its fiscal second quarter pursuant to its existing Master Note Purchase Agreement. Perrigo currently anticipates that the notes offered will consist of: $75 million of 10-year notes with an interest rate of...
-
Lannett Appoints Jeffrey Farber as Vice Chairman
Tuesday, August 16, 2011 - 7:10am | 26Lannett Company, Inc. (NYSE: LCI) today announced the appointment of Jeffrey Farber as Vice Chairman of the Board.
-
Benzinga's Top Pre-Market Gainers
Tuesday, August 16, 2011 - 6:57am | 110Wal-Mart Stores Inc (NYSE: WMT) moved up 2.26% to $51.11 in the pre-market session. WMT reported a 5.7% rise in its fiscal second-quarter net income. Home Depot Inc (The) (NYSE: HD) added 1.72% to $32.00 in the pre-market session. HD reported a 14% rise in its fiscal-second-quarter net income....
-
Forest Laboratories Sends Open Letter to Shareholders
Tuesday, August 16, 2011 - 6:51am | 130Forest Laboratories (NYSE: FRX) today sent the following open letter to all Forest shareholders in connection with the Company's Annual Meeting, which will be held on August 18, 2011. August 16, 2011 Dear Fellow Shareholders, The Forest Annual Meeting will be held in less than three days, on...
-
Benzinga's Top Upgrades
Tuesday, August 16, 2011 - 6:37am | 133Benchmark Company upgraded Hess Corporation (NYSE: HES) from “sell” to “buy.” Hess' shares closed at $60.21 yesterday. Hess' PEG ratio is 0.64. Analysts at Credit Suisse upgraded Allergan Inc (NYSE: AGN) from “neutral” to “outperform.” AGN's shares closed at $74.75 yesterday. Allergan's trailing-...
-
A Peek Into The Market Before The Trading Starts
Tuesday, August 16, 2011 - 6:30am | 383Pre-open movers US stock futures are lower this morning, as investors are awaiting economic data. Futures for the Dow Jones Industrial Average dipped 107 points to 11,296.00 and S&P 500 index futures fell 16.20 points to 1,182.20. Nasdaq 100 futures dropped 27.75 points to 2,178.75. A Peek...
-
QIAGEN and Pfizer Partner to Develop Companion Diagnostic for Novel Compound in Global Clinical Trials for Lung Cancer
Tuesday, August 16, 2011 - 5:53am | 111QIAGEN (NASDAQ: QGEN) today announced it has entered into a partnership with Pfizer Inc. (NYSE: PFE) for the development of a companion molecular diagnostic test for use with an investigational Pfizer compound in global clinical development for treatment of non-small cell lung cancer. Financial...
-
US Stock Futures Down; Wal-Mart Earnings In Focus
Tuesday, August 16, 2011 - 5:11am | 533US stock futures are lower this morning, as investors are awaiting earnings from Wal-Mart Stores Inc (NYSE: WMT). Futures for the Dow Jones Industrial Average dipped 77 points to 11,326.00 and S&P 500 index futures fell 12.60 points to 1,185.80. Nasdaq 100 futures dropped 23.50 points to 2,183....
-
Credit Suisse Upgrades Allergan To Outperform, Raises PT To $91
Tuesday, August 16, 2011 - 4:50am | 27Credit Suisse has upgraded Allergan (NYSE: AGN) from Neutral to Outperform and has raised the price target from $81 to $91.
-
Earnings Scheduled For August 16
Tuesday, August 16, 2011 - 3:19am | 481TJX Companies Inc (The) (NYSE: TJX) is expected to report its Q2 EPS at $0.89 on revenue of $5.44 billion. Home Depot Inc (The) (NYSE: HD) is projected to report its Q2 EPS at $0.83 on revenue of $19.96 billion. Saks Incorporated (NYSE: SKS) is estimated to post a Q2 loss at $0.09 per share on...